T he peripheral chemoreflex, located in the carotid bodies, is the dominant reflex control mechanism regulating the ventilatory and muscle sympathetic nerve activity (MSNA) responses to reductions in partial pressure of oxygen (PaO 2 ). 1 Peripheral chemoreceptors also play an important modulatory role in the regulation of ventilation during exercise. [2] [3] [4] [5] This is evidenced by the observation that breathing oxygen decreases ventilation and increases arterial carbon dioxide to a greater extent during exercise than at rest. 6, 7 Central chemoreceptors are located in the brain stem and respond primarily to hypercapnia. 8 These receptors exert important influences on the neural and circulatory responses to changes in arterial carbon dioxide content (PaCO 2 ). 8 Their activation increases minute ventilation (V E), heart rate (HR), blood pressure (BP), and sympathetic activity. 9 In normal subjects and athletes, there is a positive relation between V E and the rate of CO 2 production (V CO 2 ) during exercise and central chemoreceptor sensitivity at rest. 2, 5, 10 Heart failure is accompanied by increased peripheral and central chemosensitivity, 11, 12 which correlates with an in-
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creased ventilatory response to exercise. 11 The ventilatory response of heart transplant recipients (HTRs) during exercise is comparable to that of patients with moderate degrees of heart failure. 13 Thus, although heart transplantation restores a close-to-normal cardiac function, it does not normalize the ventilatory response to exercise, 14 and the mechanism of hyperpnea during exercise in HTRs remains incompletely understood.
On the basis of previous evidence that chemoreceptors are important regulators of the ventilatory response to exercise, 1 that heart failure patients have increased peripheral and central chemoreflex sensitivity, 12 and that HTRs have an increased ventilatory response to exercise, 14 we decided to test the hypothesis that chemoreceptor sensitivity is increased in HTRs and that this mechanism is related to exercise hyperpnea after heart transplantation. For this purpose, we determined minute ventilation and MSNA in HTRs with normal left ventricular ejection fraction and in closely matched referent subjects.
Methods

Subjects
The study included 19 HTRs and 11 healthy referent subjects. Healthy referent subjects were recruited by panel advertisement in our hospital. The study protocol was approved by the ethics committee of Erasme Hospital. All patients and referent subjects agreed to participate in the study.
Measurements
Patients and referent subjects were studied in supine resting conditions in a quiet experimentation room. All were instrumented to measure HR by continuous ECG recording (Siemens). BP was determined every minute by an automatic sphygmomanometer (Physiocontrol Collin BP-880). V E (pneumotacometer) and end-tidal carbon dioxide partial pressure (PetCO 2 ; M.E.C. capnometer) were assessed while subjects breathed through a mouthpiece with a nose clip, which guaranteed exclusive mouth breathing. Arterial blood oxygen was monitored continuously with a pulse oximeter (Nellcor). MSNA was recorded continuously with multiunit recordings of postganglionic sympathetic activity, measured from a nerve fascicle in the peroneal nerve posterior to the fibular head. 15 Baseline recordings were obtained for 5 minutes once subjects had reached stable ventilation.
Chemoreflex Activation
The protocol used to test the chemoreceptor responses to isocapnic hypoxia and hyperoxic hypercapnia was the same as in previous studies. 16, 17 After a 5-minute baseline period of stable ventilation, peripheral chemoreceptors were activated for 3 minutes by exposure to hypoxia (10% O 2 in 90% of N 2 ); activation of central chemoreceptors was prevented during these 3 minutes by adding carbon dioxide to the inspired gas mixture. Central chemoreceptors were activated by hyperoxic hypercapnia (7% CO 2 and 93% O 2 ) for 3 minutes, again after a 5-minute baseline period of stable ventilation; maintenance of hyperoxia during central chemoreceptor stimulation minimized the activation of peripheral chemoreceptors. The sequence of central and peripheral chemoreflex activation was randomized in all subjects. A 15-minute rest period was ensured between the first intervention and the next 5-minute baseline period of stable ventilation.
Changes in the cardiorespiratory variables during central chemoreceptor testing are presented as means of the 3-minute exposures to hypercapnia. During peripheral chemoreceptor testing, changes in cardiorespiratory variables are presented minute by minute during 3-minute exposure to hypoxia.
Cardiopulmonary Exercise Testing
Sixteen HTRs and 10 referent subjects underwent a maximum, symptom-limited exercise test on the cycle ergometer. They started with 1-minute unloaded pedaling; the load was subsequently increased by 10 W every minute. Expired gas was collected in the mixing chamber and sampled with an O 2 and CO 2 analyzer while V E was also recorded (SensorMedics Corp). Ventilation and gas concentrations were averaged over 30 seconds, and from these values, V E, the rate of oxygen uptake (V O), the rate of carbon dioxide production (V CO 2 ), and the respiratory exchange ratio were derived. HR was recorded by a continuously monitored ECG, and systolic and diastolic BPs were determined at the end of each workload by an automatic sphygmomanometer. Peak V O was defined as the V O during the last 30 seconds of peak exercise.
The adequacy of ventilation/perfusion matching was assessed by determining the ratio of physiological dead space to tidal volume ratio (VD/VT) at the beginning of the exercise (while subjects were pedaling 20 W for 30 seconds) and at peak exercise. VD/VT was calculated from the Bohr equation. 18 PetCO 2 was used as an estimate of PaCO 2 . 19 
Statistical Analysis
All the data except variables during hyperoxic hypercapnia are presented as meanϮSE. Variables during central chemoreceptor sensitivity testing were not distributed normally and are presented as medians (interquartile [IC] ). Baseline quantitative variables were compared by unpaired t test. Responses to hypoxia were compared by ANOVA, with time (baseline versus intervention) and group as the factors. The group-by-time interaction was tested. Because the hypoxic ventilatory response correlates to the body surface area, 2, 20, 21 changes in ventilation in response to hypoxia were normalized for body surface area and related to the ventilatory response to exercise (characterized by the regression slope relating ventilation to CO 2 output during exercise, V E/V CO 2 slope) through linear regression analysis. 11 Responses to hypercapnia were compared by a Mann-Whitney test. Ventilatory responses to hypercapnia at rest were related to the V E/V CO 2 slope during exercise with Spearman correlation coefficients. The level of statistical significance was fixed at PϽ0.05.
Results
Subjects
Nineteen (14 male) HTRs (age, 54Ϯ3 years; body mass index, 26Ϯ1 kg/m 2 ) and 11 (9 male) referent subjects (age, 50Ϯ4 years; body mass index, 25Ϯ1 kg/m 2 ) matched for age, gender, and body mass index took part in our study. The mean time from heart transplantation was 7.2Ϯ1.1 years (range, 1.0 to 16.5 years). HTRs had normal left ventricular ejection fraction estimated by echocardiography (60Ϯ2%; nϭ13) and/or by resting radionuclide ventriculography (59Ϯ3%; nϭ18). HTRs were on various combinations of immunosuppressive treatment and were receiving cyclosporine (nϭ17), azathioprine (nϭ6), tacrolimus (nϭ1), and mofetil mycocenolate (nϭ3). Some HTRs also were taking calcium channel blockers (nϭ9), angiotensin-converting enzyme inhibitors (nϭ11), ␤-blockers (nϭ4), and diuretics (nϭ8). No patient suffered from acute allograft rejection at the time of the study. One patient was diabetic and was on oral antidiabetic treatment. For ethical reasons, medication was left unchanged in the HTRs. All referent subjects had a normal physical examination, and none was taking any medication.
Baseline Room Air Breathing
HTRs had higher MSNA (52Ϯ4 versus 34Ϯ3 bursts/min; PϽ0.01) and faster HRs (83Ϯ3 versus 68Ϯ3 bpm; PϽ0.01) than the referent subjects. Mean arterial BP of 107Ϯ3 mm Hg was higher in the HTRs than in the referent subjects (98Ϯ3 mm Hg), but the difference was not significant. Both groups had nearly identical arterial blood oxygen saturations (96.4Ϯ0.3% versus 96.2Ϯ0.4% in the HTRs and referent group, respectively; PϭNS). V E was slightly larger (6.8Ϯ0.2 versus 6.5Ϯ0.2 L/min) in HTRs than in the referent subjects, but the difference was not significant (PϭNS). PetCO 2 was lower (35Ϯ1 versus 39Ϯ1 mm Hg; PϽ0.01) in the HTRs than in the referent group.
Isocapnic Hypoxia
The increases in V E in response to the 3 minutes of hypoxia were more marked in the HTRs than in the referent subjects (PϽ0.01, ANOVA) despite identical reductions in arterial oxygen saturation ( Figure 1 and Figure 2 ). The enhanced ventilatory response to hypoxia was also paralleled by a larger rise in MSNA in the HTRs (PϽ0.05, ANOVA) ( Figure  1 and Figure 2 ). Mean BP and PetCO 2 changes were comparable in the 2 groups (PϭNS, ANOVA), whereas the increase in HR was less marked in the HTRs (PϽ0.01, ANOVA). 
Hypercapnic Hyperoxia
Cardiopulmonary Exercise Testing
HTRs and referent subjects achieved the same respiratory exchange ratio, but HTRs had lower peak V O, lower peak load in Watts, lower anaerobic threshold, lower peak V E, lower peak oxygen pulse, higher peak V E/V O, and higher peak V E/V CO 2 ( Table 2) 
Chemosensitivity and the Ventilatory Response to Exercise
The V E/V O slope during exercise in the HTR patients was positively correlated to peripheral chemosensitivity at rest, expressed as the ratio between the rise in ventilation and the reduction in oxygen saturation during the 3 minutes of hypoxia normalized for body surface area, as shown in Figure 3 (rϭ0.57; nϭ16; PϽ0.05). The V E/V CO 2 slope during exercise in HTRs was also directly related to central chemosensitivity at rest, expressed as the ratio between V E and PetCO 2 during the 3 minutes of hypercapnia (R Spearman ϭ0.50, PϽ0.05).
The V E/V CO 2 slope in HTRs was related to peak PetCO 2 (rϭ0.67, Pϭ0.0001), but it was not related to peak VD/VT (rϭ0.25, Pϭ0.36).
Discussion
The original finding of this study is that peripheral chemoreceptor sensitivity is increased in HTRs and may contribute to abnormally increased V E during exercise in HTRs. To the best of our knowledge, this is the first study to assess chemoreflex control after cardiac transplantation.
Previous studies have shown that patients with congestive heart failure present with a high V E/V CO 2 ratio during exercise, 11 and this is associated with a poor prognosis. 22 The increase in the V E/V CO 2 ratio during exercise in congestive heart failure is explained by altered ventilation/perfusion matching 23 and by early lactic acidosis, 23 but also by increased chemoreceptor gain for both PaO 2 and PaCO 2 . 17, 22, 24 This augmented exercise-induced increase in ventilation in congestive heart failure is related to impaired autonomic and baroreceptor control as manifested by increased MSNA, 17 decreased HR variability, and increased BP variability with predisposition to arrhythmia and sudden death. 25 Our present study shows that heart transplantation does not restore normal peripheral chemoreceptor function.
Peripheral Chemoreflex Sensitivity
The increased peripheral chemoreflex sensitivity we observed in our HTRs cannot be explained by differences in resting oxygen saturation between the HTRs and referent subjects or by left ventricular systolic dysfunction in the patients. The trend toward a larger baseline V E and lower PetCO 2 in the presence of identical oxygen saturations in HTRs suggests that these patients also present with increased chemoreflex sensitivity under resting normoxemic conditions. These results are in keeping with our previous observation that HTRs compared with controls present with higher resting peripheral chemoreceptor drive with increased sympathetic nervous system tone under normoxemic conditions, 26 which further suggested altered chemoreflex control in HTRs. Hyperventilation inhibits the sympathetic nerve response to chemoreflex activation through activation of pulmonary stretch afferents. 27 Our observation of increased sympathetic nerve response to hypoxia in the presence of increased V E supports the importance of peripheral chemoreflex enhancement of MSNA after cardiac transplantation. It is unlikely that the lower PetCO 2 in the HTRs can explain our findings. If anything, the slightly lower PetCO 2 would have hampered the ventilatory and sympathetic response to hypoxia in the HTRs.
There are several possible explanations for the enhancement of peripheral chemoreceptor sensitivity in HTRs. First, denervation of the transplanted heart and associated cardiopulmonary baroreceptor dysfunction could increase peripheral chemoreceptor sensitivity by a mechanism similar to the cardiopulmonary baroreceptor unloading by changes in body position in healthy subjects. 28 Second, impairment of arterial baroreceptor sensitivity by chronic cyclosporine intake 29 may attenuate inhibitory stimuli toward peripheral chemoreceptors 30 and result in a net increase in the sensitivity to hypoxia. Third, systemic arterial hypertension may enhance peripheral chemoreceptor sensitivity to an extent similar to that in patients with essential hypertension. 31 Finally, mechanisms associated with increased peripheral chemoreceptor sensitivity in heart failure 12, 17, 22, 24 could have a lingering effect on chemoreceptor function in patients after cardiac transplantation.
Central Chemoreflex Sensitivity
This study also demonstrates that HTRs have a normal ventilatory and MSNA response to hypercapnia while maintaining an abnormal response to isocapnic hypoxia. It is interesting to speculate why central chemoreceptor sensitivity is normalized while peripheral chemosensitivity remains altered in this group of patients. One possible cause of this apparent discrepancy may relate to the inhibitory interaction between the arterial and cardiopulmonary baroreceptors and the peripheral chemoreceptors. In HTRs, cardiac baroreceptor afferents are cut and become dysfunctional. Arterial baroreceptor sensitivity is impaired because of chronic cyclosporine uptake. 29 The close proximity of baroreceptor and chemoreceptor neurons in the solitary and paramedian reticular nuclei in the medulla could explain the interactions between these reflexes 30, 32 ; however, such an interference between baroreceptors and central chemoreceptors has not been described. Thus, although the surgical procedure improves cardiac function, which may favor normalization of central chemoreceptor sensitivity, it also alters inhibitory loops and necessitates drug treatments, which may suppress baroreflex restraint on peripheral chemoreflex control. This issue requires further investigation.
Exercise Hyperpnea
Our results are consistent with observations that cardiac transplantation does not normalize exercise hyperpnea after cardiac transplantation. 14 The exact mechanisms of the increased ventilatory response to exercise in HTRs remain unclear. Ventilation perfusion abnormalities resulting in increased dead space ventilation from an attenuated cardiac chronotropic response to exercise, respiratory muscle weakness, and hypoperfusion have been suggested to explain exercise hyperpnea in HTRs. 14 Our HTRs disclosed a VD/VT ratio similar to that of the referent group at the beginning and end of the ergospirometry. However, because the use of PetCO 2 instead of PaCO 2 may lead to underestimation of VD/VT, 33, 34 we cannot exclude that increased VD/VT contributed to exercise hyperpnea in our HTRs. Nevertheless, we believe that the VD/VT contribution to exercise hyperpnea is likely to be of minor importance in HTRs. This is based on the following observations. First, we estimated PaCO 2 in HTRs and control subjects using the following formula: PaCO 2 ϭ5.5ϩ(0.9ϫPetCO 2 )Ϫ(0.0021ϫVT), as suggested by Jones et al. 19 This method of PaCO 2 estimation is used in clinical studies on heart failure patients when only end-tidal PetCO 2 is measured. 35 Afterward, we recalculated VD/VT using PaCO 2 in the Bohr equation. Although we observed a small difference between VD/VT in the patients and control subjects at rest, we still could not find a significant difference between the 2 groups at peak exercise (Pϭ0.84). Second, the V E/V CO 2 slope correlated strongly with peak PetCO 2 , but it was not related to peak VD/VT in HTRs. This further suggests that increased ventilation during exercise in HTRs is an integral part of deranged cardiorespiratory control rather than an impaired ventilation/perfusion matching in the lungs. 36 Another important finding of our study is that exercise hyperpnea, assessed by the V E/V CO 2 slope, is related to chemoreceptor sensitivity to hypoxia after transplantation. This is in accordance with previous observations that peripheral chemoreceptors, which sense the oscillations in Hϩ-PaCO 2 , Kϩ, catecholamines, and body temperature, 37 play an important modulatory role in the regulation of ventilation during exercise. 2,4 -7 The ventilatory response to exercise in normal humans, 2,5 as well as in patients with heart failure, 11 is positively related to chemosensitivity determined in resting conditions. Our study extends this observation to HTRs and suggests that increased peripheral chemoreflex sensitivity and exercise hyperpnea share common pathophysiological mechanisms in these patients.
The last interesting finding is that central chemosensitivity at rest is also related to ventilatory response to exercise in HTRs. The ventilatory response to hypercapnia correlates to the ventilatory response to exercise in normal subjects and athletes 4, 5, 10 ; we extend this observation to patients after heart transplantation. However, the ventilatory response from central chemoreceptors was strictly normal in these HTRs. Thus, central chemoreceptor sensitivity contributes to ventilation during exercise but cannot explain the exercise hyperpnea.
In conclusion, our study is the first to demonstrate increased peripheral chemoreceptor sensitivity in HTRs. The increased ventilatory response to exercise observed in HTRs is related to resting peripheral chemoreflex hypersensitivity.
Study Limitations
A positive correlation between the ventilatory response to hypoxia and exercise V E/V CO 2 does not necessarily imply a cause-effect relationship because of the complex pathophysiology that sustains exercise hyperpnea. Other potential limitations to our study are the fact that the data analysis was not performed in a blinded fashion; the possibility that hypertension, almost always accompanying heart transplantation, may have contributed to our findings; and, as discussed above, the absence of PaCO 2 measurements.
CLINICAL PERSPECTIVE
Heart failure is characterized by decreased exercise capacity and abnormally increased ventilatory response to exercise. The ventilatory response to exercise, however, remains comparable to that of patients with moderate heart failure after successful heart transplantation. Several mechanisms such as chronotropic incompetence, increased dead space ventilation in the presence of ventilation-perfusion abnormalities, and abnormal muscle reflex regulation can account for this observation. Pulmonary function also can affect pulmonary gas exchange and increase ventilation once the critical value of lung diffusion capacities is attained. We tested the hypothesis that exercise hyperpnea is related to an abnormal chemoreceptor regulation after transplantation. Our study demonstrates that HTRs have an increased peripheral chemoreceptor sensitivity and that this hypersensitivity is related to exercise hyperpnea. Central chemosensitivity was not increased but was similarly related to exercise hyperpnea. These findings reveal that chemoreflex regulation and exercise intolerance are linked by common regulatory mechanisms. The clinical impact of this finding is that it calls for further research on therapeutic interventions that may affect chemoreflex sensitivity and improve exercise tolerance. Whether exercise training, specific cardiovascular medications, or the treatment of associated conditions can improve chemoreceptor sensitivity in HTRs is not known. Whether improvements in chemoreflex control can translate into less exercise intolerance after transplantation also needs further investigation. This research may enable clinicians to better choose among different treatment modalities to become more successful in improving exercise tolerance after transplantation.
